{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:47:23Z","timestamp":1782226043129,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"DOI":"10.7759\/cureus.73765","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:22:43Z","timestamp":1731691363000},"source":"Crossref","is-referenced-by-count":4,"title":["Study of Imaging Biomarkers as a Prognostic Factor and Guide in the Management of Diabetic Macular Oedema"],"prefix":"10.7759","author":[{"given":"Nikita","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Som","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetic macular edema","volume":"59","author":"Musat O","year":"2015","unstructured":"Musat O, Cernat C, Labib M, Gheorghe A, Toma O, Zamfir M, Boureanu AM. Diabetic macular edema. Rom J Ophthalmol. 2015, 59:133-6.","journal-title":"Rom J Ophthalmol"},{"key":"ref2","article-title":"Diabetic retinopathy","author":"Shukla UV","year":"2023","unstructured":"Shukla UV, Tripathy K. Diabetic retinopathy. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.9.2653","article-title":"Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies","volume":"26","author":"Ciulla TA","year":"2003","unstructured":"Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003, 26:2653-64. 10.2337\/diacare.26.9.2653","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52676","article-title":"Diabetic macular edema management: a review of anti-vascular endothelial growth factor (VEGF) therapies","volume":"16","author":"Cheema AA","year":"2024","unstructured":"Cheema AA, Cheema HR. Diabetic macular edema management: a review of anti-vascular endothelial growth factor (VEGF) therapies. Cureus. 2024, 16:e52676. 10.7759\/cureus.52676","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2007.00151.x","article-title":"Clinical applications and new developments of optical coherence tomography: an evidence-based review","volume":"90","author":"Chen J","year":"2007","unstructured":"Chen J, Lee L. Clinical applications and new developments of optical coherence tomography: an evidence-based review. Clin Exp Optom. 2007, 90:317-35. 10.1111\/j.1444-0938.2007.00151.x","journal-title":"Clin Exp Optom"},{"key":"ref6","article-title":"Macular edema","author":"Kohli P","year":"2024","unstructured":"Kohli P, Tripathy K, Patel BC. Macular edema. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000458539","article-title":"Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)","volume":"237","author":"Schmidt-Erfurth U","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al.. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017, 237:185-222. 10.1159\/000458539","journal-title":"Ophthalmologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/2515841420950513","article-title":"Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema","volume":"12","author":"Markan A","year":"2020","unstructured":"Markan A, Agarwal A, Arora A, Bazgain K, Rana V, Gupta V. Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema. Ther Adv Ophthalmol. 2020, 12:2515841420950513. 10.1177\/2515841420950513","journal-title":"Ther Adv Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111161","article-title":"Quantitative imaging biomarkers in age-related macular degeneration and diabetic eye disease: a step closer to precision medicine","volume":"11","author":"Kalra G","year":"2021","unstructured":"Kalra G, Kar SS, Sevgi DD, Madabhushi A, Srivastava SK, Ehlers JP. Quantitative imaging biomarkers in age-related macular degeneration and diabetic eye disease: a step closer to precision medicine. J Pers Med. 2021, 11:1161. 10.3390\/jpm11111161","journal-title":"J Pers Med"},{"key":"ref10","unstructured":"Advanced visual acuity. Accessed. October 28, 2024: https:\/\/www.spectrumeyecaresoftware.com\/advanced-visual-acuity\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(13)38009-9","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","unstructured":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991, 98.741-56. 10.1016\/s0161-6420(13)38009-9","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6655021","article-title":"Optical coherence tomography (angiography) biomarkers in the assessment and monitoring of diabetic macular edema","volume":"2020","author":"Suciu CI","year":"2020","unstructured":"Suciu CI, Suciu VI, Nicoara SD. Optical coherence tomography (angiography) biomarkers in the assessment and monitoring of diabetic macular edema. J Diabetes Res. 2020, 2020:6655021. 10.1155\/2020\/6655021","journal-title":"J Diabetes Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30432-2","article-title":"Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema","volume":"13","author":"Borrelli E","year":"2023","unstructured":"Borrelli E, Barresi C, Feo A, et al.. Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema. Sci Rep. 2023, 13:3224. 10.1038\/s41598-023-30432-2","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.031","article-title":"OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant","volume":"125","author":"Zur D","year":"2018","unstructured":"Zur D, Iglicki M, Busch C, Invernizzi A, Mariussi M, Loewenstein A, International Retina Group. OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant. Ophthalmology. 2018, 125:267-75. 10.1016\/j.ophtha.2017.08.031","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000314720","article-title":"Is prevalence of retinopathy related to the age of onset of diabetes? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Report No. 5","volume":"45","author":"Raman R","year":"2011","unstructured":"Raman R, Vaitheeswaran K, Vinita K, Sharma T. Is prevalence of retinopathy related to the age of onset of diabetes? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Report No. 5. Ophthalmic Res. 2011, 45:36-41. 10.1159\/000314720","journal-title":"Ophthalmic Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000508335","article-title":"Prevalence of and risk factors for diabetic retinopathy and diabetic macular edema in patients with early- and late-onset diabetes mellitus","volume":"65","author":"Wang Y","year":"2022","unstructured":"Wang Y, Lin Z, Zhai G, et al.. Prevalence of and risk factors for diabetic retinopathy and diabetic macular edema in patients with early- and late-onset diabetes mellitus. Ophthalmic Res. 2022, 65:293-9. 10.1159\/000508335","journal-title":"Ophthalmic Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47993","article-title":"Prevalence and risk factors of retinopathy in type 1 diabetes: a cross-sectional study","volume":"15","author":"Berrabeh S","year":"2023","unstructured":"Berrabeh S, Elmehraoui O, Benouda S, Assarrar I, Rouf S, Latrech H. Prevalence and risk factors of retinopathy in type 1 diabetes: a cross-sectional study. Cureus. 2023, 15:e47993. 10.7759\/cureus.47993","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147585","article-title":"The role of intravitreal corticosteroids in the treatment of DME: predictive OCT biomarkers","volume":"23","author":"Munk MR","year":"2022","unstructured":"Munk MR, Somfai GM, de Smet MD, Donati G, Menke MN, Garweg JG, Ceklic L. The role of intravitreal corticosteroids in the treatment of DME: predictive OCT biomarkers. Int J Mol Sci. 2022, 23:7585. 10.3390\/ijms23147585","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3459164","article-title":"Association between hyperreflective foci on spectral-domain optical coherence tomography and early recurrence of diabetic macular edema after intravitreal dexamethasone implantation","volume":"2019","author":"Kim KT","year":"2019","unstructured":"Kim KT, Kim DY, Chae JB. Association between hyperreflective foci on spectral-domain optical coherence tomography and early recurrence of diabetic macular edema after intravitreal dexamethasone implantation. J Ophthalmol. 2019, 2019:3459164. 10.1155\/2019\/3459164","journal-title":"J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2627_20","article-title":"Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: retrospective analysis of treatment na\u00efve eyes from south India","volume":"69","author":"Arthi M","year":"2021","unstructured":"Arthi M, Sindal MD, Rashmita R. Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: retrospective analysis of treatment na\u00efve eyes from south India. Indian J Ophthalmol. 2021, 69:1197-202. 10.4103\/ijo.IJO_2627_20","journal-title":"Indian J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041303","article-title":"Prognostic imaging biomarkers in diabetic macular edema eyes treated with intravitreal dexamethasone implant","volume":"12","author":"Costanzo E","year":"2023","unstructured":"Costanzo E, Giannini D, De Geronimo D, Fragiotta S, Varano M, Parravano M. Prognostic imaging biomarkers in diabetic macular edema eyes treated with intravitreal dexamethasone implant. J Clin Med. 2023, 12:1303. 10.3390\/jcm12041303","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84553-7","article-title":"Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy","volume":"11","author":"Huang CH","year":"2021","unstructured":"Huang CH, Yang CH, Hsieh YT, Yang CM, Ho TC, Lai TT. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy. Sci Rep. 2021, 11:5103. 10.1038\/s41598-021-84553-7","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5639284","article-title":"Optical coherence tomography parameters related to vision impairment in patients with diabetic macular edema: a quantitative correlation analysis","volume":"2020","author":"Li B","year":"2020","unstructured":"Li B, Zhang B, Chen Y, Li D. Optical coherence tomography parameters related to vision impairment in patients with diabetic macular edema: a quantitative correlation analysis. J Ophthalmol. 2020, 2020:5639284. 10.1155\/2020\/5639284","journal-title":"J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.6256","article-title":"Disorganization of inner retina and outer retinal morphology in diabetic macular edema","volume":"136","author":"Das R","year":"2018","unstructured":"Das R, Spence G, Hogg RE, Stevenson M, Chakravarthy U. Disorganization of inner retina and outer retinal morphology in diabetic macular edema. JAMA Ophthalmol. 2018, 136:202-8. 10.1001\/jamaophthalmol.2017.6256","journal-title":"JAMA Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta H","year":"2018","unstructured":"Mehta H, Tufail A, Daien V, et al.. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res. 2018, 65:127-46. 10.1016\/j.preteyeres.2017.12.002","journal-title":"Prog Retin Eye Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308367-study-of-imaging-biomarkers-as-a-prognostic-factor-and-guide-in-the-management-of-diabetic-macular-oedema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:22:44Z","timestamp":1731691364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308367-study-of-imaging-biomarkers-as-a-prognostic-factor-and-guide-in-the-management-of-diabetic-macular-oedema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.73765","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}